| (84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE
SI SK TR |
| (30) |
Priority: |
01.03.2006 US 778471 P
21.03.2006 US 784576 P
30.03.2006 US 396216
30.03.2006 US 395197
|
| (43) |
Date of publication of application: |
|
19.11.2008 Bulletin 2008/47 |
| (60) |
Divisional application: |
|
14193181.6 |
| (73) |
Proprietor: Aduro Biotech |
|
Berkeley, California 94710-2225 (US) |
|
| (72) |
Inventors: |
|
- DUBENSKY, Thomas, W., Jr.
Piedmont, CA 94611 (US)
- SKOBLE, Justin
Berkeley, CA 94703 (US)
- LAUER, Peter, M.
Albany, CA 94706 (US)
- COOK, David, N.
Lafayette, CA 94549 (US)
|
| (74) |
Representative: Brasnett, Adrian Hugh et al |
|
Mewburn Ellis LLP
33 Gutter Lane
London EC2V 8AS
London EC2V 8AS (GB) |
| (56) |
References cited: :
WO-A-2004/110481
|
WO-A-2005/071088
|
|
| |
|
|
- BROCKSTEDT DIRK G ET AL: "Recombinant listeria monocytogenes-based immunotherapy targeting
mesothelin for the treatment of pancreatic and ovarian cancer." PROCEEDINGS OF THE
AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING, vol. 46, April 2005 (2005-04),
page 1418, XP001536813 & 96TH ANNUAL MEETING OF THE AMERICAN-ASSOCIATION-FOR-CANCER-RESEARCH;
ANAHEIM, CA, USA; APRIL 16 -20, 2005 ISSN: 0197-016X
- BROCKSTEDT D G ET AL: "Listeria-based cancer vaccines that segregate immunogenicity
from toxicity" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY
OF SCIENCE, WASHINGTON, DC, US, vol. 101, no. 38, 21 September 2004 (2004-09-21),
pages 13832-13837, XP002305523 ISSN: 0027-8424
|
|
